Dr. Victor C Urrutia, MD
Claim this profileMore about Victor C Urrutia, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Victor C Urrutia, MD has experience with
- Guideline Recommended Standard Monitoring
- Low-intensity Monitoring Strategy
Breakdown of trials Victor C Urrutia, MD has run
Acute Ischemic Stroke Therapy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Victor C Urrutia, MD specialize in?
Victor C Urrutia, MD focuses on Acute Ischemic Stroke Therapy and other conditions. In particular, much of their work with Acute Ischemic Stroke Therapy has involved treating patients, or patients who are undergoing treatment.
Is Victor C Urrutia, MD currently recruiting for clinical trials?
No, Victor C Urrutia, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Victor C Urrutia, MD has studied deeply?
Yes, Victor C Urrutia, MD has studied treatments such as Guideline recommended standard monitoring, Low-intensity monitoring strategy.
What is the best way to schedule an appointment with Victor C Urrutia, MD?
Apply for one of the trials that Victor C Urrutia, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.